Eiji Sato

发表

Phase I clinical study of anti-apoptosis protein survivin-derived peptide vaccination for patients with advanced or recurrent urothelial cancer

N. Sato, N. Masumori, H. Kitamura, 2009, Cancer Immunology, Immunotherapy.

Hypoxia-inducible factor (HIF)-independent expression mechanism and novel function of HIF prolyl hydroxylase-3 in renal cell carcinoma

N. Sato, N. Masumori, H. Kitamura, 2014, Journal of Cancer Research and Clinical Oncology.

Human leukocyte antigen class I down‐regulation in muscle‐invasive bladder cancer: Its association with clinical characteristics and survival after cystectomy

N. Sato, N. Masumori, H. Kitamura, 2009, Cancer science.

α1‐blocker tamsulosin as initial treatment for patients with benign prostatic hyperplasia: 5‐year outcome analysis of a prospective multicenter study

N. Masumori, T. Tsukamoto, N. Miyao, 2013, International journal of urology : official journal of the Japanese Urological Association.

Effects of a new immunosuppressive agent, β-SQAG9, in swine kidney transplantation

H. Inoko, K. Sakaguchi, F. Sugawara, 2007 .

COMPARISON OF SPEEDY PCR-SSP METHOD AND SEROLOGICAL TYPING OF HLA-A24 FOR JAPANESE CANCER PATIENTS

N. Sato, Y. Tamura, Y. Hirohashi, 2011, Journal of immunoassay & immunochemistry.

Removal of more lymph nodes may provide better outcome, as well as more accurate pathologic findings, in patients with bladder cancer--analysis of role of pelvic lymph node dissection.

N. Masumori, H. Kitamura, M. Tamakawa, 2006, Urology.

Local recurrence after radical cystectomy for invasive bladder cancer: an analysis of predictive factors.

N. Masumori, T. Tsukamoto, N. Itoh, 2004, Urology.

Expression and antigenicity of survivin, an inhibitor of apoptosis family member, in bladder cancer: implications for specific immunotherapy.

N. Sato, H. Kitamura, Y. Hirohashi, 2006, Urology.

Aberrant expression and potency as a cancer immunotherapy target of alpha-methylacyl-coenzyme A racemase in prostate cancer

N. Sato, N. Masumori, H. Kitamura, 2009, Journal of Translational Medicine.

Identification of an Immunogenic CTL Epitope of HIFPH3 for Immunotherapy of Renal Cell Carcinoma

N. Sato, N. Masumori, H. Kitamura, 2008, Clinical Cancer Research.

Effects of a new immunosuppressive agent, beta-SQAG9, in swine kidney transplantation.

H. Inoko, K. Sakaguchi, F. Sugawara, 2007, Transplant immunology.

Autoantibody against hypoxia-inducible factor prolyl hydroxylase-3 is a potential serological marker for renal cell carcinoma

N. Sato, N. Masumori, H. Kitamura, 2011, Journal of Cancer Research and Clinical Oncology.

Effect of Human Leukocyte Antigen Class I Expression of Tumor Cells on Outcome of Intravesical Instillation of Bacillus Calmette-Guerin Immunotherapy for Bladder Cancer

N. Sato, H. Kitamura, Y. Hirohashi, 2006, Clinical Cancer Research.

Expression of livin in renal cell carcinoma and detection of anti-livin autoantibody in patients.

N. Sato, H. Kitamura, Y. Hirohashi, 2007, Urology.

Human leukocyte antigen class I down‐regulation in muscle‐invasive bladder cancer: Its association with clinical characteristics and survival after cystectomy

N. Sato, N. Masumori, H. Kitamura, 2009, Cancer science.

COMPARISON OF SPEEDY PCR-SSP METHOD AND SEROLOGICAL TYPING OF HLA-A24 FOR JAPANESE CANCER PATIENTS

N. Sato, Y. Tamura, Y. Hirohashi, 2011, Journal of immunoassay & immunochemistry.